Heart failure medication dosage and survival in women and men seen at outpatient clinics

Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women

(2019) Sophie H. Bots et al.   JACC-Heart Failure

Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study

(2019) Clare J Taylor et al.   BMJ-British Medical Journal

Recommended Heart Failure Medications and Adverse Drug Reactions in Women

(2019) Sophie H. Bots et al.   CIRCULATION

Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study

(2019) Bernadet T Santema et al.   LANCET

Participation of Women in Clinical Trials

(2018) Louise Pilote et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs

(2018) Pamela E. Scott et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sex differences in ischemic heart disease and heart failure biomarkers

(2018) Kimia Sobhani et al.   Biology of Sex Differences

Plasma Levels of BNP Are Lower in Women Than Men among Patients with HFpEF

(2017) Eisaku Harada et al.   JOURNAL OF CARDIAC FAILURE

Comparison of Propensity Score Methods and Covariate Adjustment

(2017) Markus C. Elze et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Epidemiology of heart failure with preserved ejection fraction

(2017) Shannon M. Dunlay et al.   Nature Reviews Cardiology

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure

(2016) Mitja Lainscak et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Baseline Functional Class and Therapeutic Efficacy of Common Heart Failure Interventions: A Systematic Review and Meta-analysis

(2015) Robert J.H. Miller et al.   CANADIAN JOURNAL OF CARDIOLOGY

Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC: Figure 1

(2015) Giuseppe M.C. Rosano et al.   EUROPEAN HEART JOURNAL

ipw: AnRPackage for Inverse Probability Weighting

(2015) Willem M. van der Wal et al.   Journal of Statistical Software

Adherence to therapy and adverse drug reactions: is there a link?

(2014) Christian Leporini et al.   Expert Opinion On Drug Safety

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact

(2013) John J. V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

EURObservationalResearch Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

(2013) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough

(2011) Sergi Mas et al.   Pharmacogenetics and Genomics

Sex Differences in Pharmacokinetics and Pharmacodynamics

(2009) Offie P. Soldin et al.   CLINICAL PHARMACOKINETICS